on semaglutide and not losing weight Why am I (Ozempic/Wegovy)? Why Am I Not Losing

Join LifeMD Today Join LifeMD Today See why real patients choose LifeMD

NICE guidance (NG28) recommends GLP-1 receptor agonists for adults with type 2 diabetes in specific clinical circumstances

The feedback mechanism stays intact

At Felix, were very hopeful that the upcoming release of generic semaglutide in Canada will improve both the accessibility and affordability of these treatments for our patients across the country

Tool: Walking & Creativity (02:29:53) Body Language (02:33:01) Perfectionism

Protocols may include peptide therapy, NAD+, weight management support, and lifestyle guidance, but only when medically appropriate, and only after we understand your full health picture